Search

everythinglearnresearchcommunity

for

Search:↓

Cytokeratin-15 loss is not specific to any single type of scarring alopecia.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

A condition with certain scalp changes may come before acne keloidalis nuchae and other similar hair loss disorders.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Alopecia can often be managed effectively with various treatments, but early diagnosis is crucial for preventing permanent hair loss.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Lymecycline may help with Frontal Fibrosing Alopecia but needs more research.

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.

Some women with common hair loss may develop permanent hair loss.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

Lupus can look like hair loss from alopecia areata but needs different treatment.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

Some cases of tinea capitis, a fungal scalp infection, can look like scarring hair loss due to the body's immune response and the fungus itself.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

Primary cicatricial alopecia significantly reduces life quality, mainly due to pain and anxiety.

CCCA is a common, progressive hair loss condition that may not always be linked to hair care practices and requires a biopsy for diagnosis.

Cutting scalp biopsies in consecutive slices improves diagnosis of hair loss conditions.

Two siblings both had a rare case of alopecia areata at the same time.

Shorter telomeres in white blood cells may increase the risk of a common type of hair loss.

Regenerative cellular therapies show promise for treating non-scarring hair loss but need more research.

A high neutrophil-to-lymphocyte ratio may predict poor response to hair loss treatment.

Janus kinase inhibitors may effectively treat resistant scalp conditions like folliculitis decalvans and dissecting cellulitis.

Accurate diagnosis and early treatment are crucial for managing hair loss effectively.

Microinfusion of methotrexate can help treat frontal fibrosing alopecia.

Disrupted cholesterol production impairs hair follicle stem cells, leading to hair loss.

31% of female high school students in Minia have hair loss from tight hairstyles, which can become permanent if not treated early.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Blocking cholesterol production may help control hair loss in Primary Cicatricial Alopecia by affecting key regulators.